Sources: 12Gene Ontology See all sources |
Cellular components related to hepatopulmonary syndrome according to GeneDecks: (show all 16)
| id | Name | GO ID | Score | Top Affiliating Genes | | 1 | caveola | GO:005901 | 10.5 | NOS3, PTGIS, HMOX1, CAV1, CAV2, CAV3 | | 2 | SMAD protein complex | GO:071141 | 10.1 | SMAD4, SMAD3, SMAD2 | | 3 | extracellular matrix | GO:031012 | 9.8 | SOD1, THBS1, COL18A1, PLAT, TNC, SERPINE1 | | 4 | protein complex | GO:043234 | 9.7 | SOD1, PRKCA, NR0B2, CAV1, CAV2, ALB | | 5 | membrane raft | GO:045121 | 9.5 | SLC6A4, PRKCA, EDNRA, TNF, CAV1, CAV2 | | 6 | platelet alpha granule lumen | GO:031093 | 9.3 | TGFB1, THBS1, PLG, ALB, VEGFA, SERPINE1 | | 7 | external side of plasma membrane | GO:009897 | 9.2 | THBS1, TLR2, ACE, TNF, ENG, VWF | | 8 | neuronal cell body | GO:043025 | 9.1 | SOD1, PRKCA, TGFB1, ACVRL1, CYP19A1, CCL2 | | 9 | proteinaceous extracellular matrix | GO:005578 | 8.8 | TGFB1, ELN, TNC, MMP9, MMP3, MMP2 | | 10 | cell surface | GO:009986 | 8.0 | PLAT, PLAU, ACVRL1, ELANE, TLR2, THBD | | 11 | nucleoplasm | GO:005654 | 7.9 | NR1H4, NR1I2, SMAD2, SMAD3, SMAD4, NFKB1 | | 12 | cytosol | GO:005829 | 7.0 | NFKB1, NOS3, NOS2, SMOX, SMAD4, SMAD3 | | 13 | plasma membrane | GO:005886 | 6.6 | TLR2, ACE, C4A, EDNRB, EDNRA, NOS3 | | 14 | extracellular region | GO:005576 | 5.6 | COL18A1, PLG, PLAU, PLAT, CRP, TNC | | 15 | extracellular space | GO:005615 | 5.3 | GDF2, PTGIS, CRP, PLAT, PLAU, PLG | | 16 | nucleus | GO:005634 | 5.0 | NOX4, NOS3, NOS2, SMOX, SMAD4, SMAD3 |
Biological processes related to hepatopulmonary syndrome according to GeneDecks: (show top 50)
(show all 108)
| id | Name | GO ID | Score | Top Affiliating Genes | | 1 | positive regulation of BMP signaling pathway | GO:030513 | 10.5 | SMAD4, GDF2, ACVRL1, BMPR2, ENG, SMAD2 | | 2 | superoxide anion generation | GO:042554 | 10.5 | EDN1, NOX4, NOX1, CYBB, DUOX1, SOD1 | | 3 | vasoconstriction | GO:042310 | 10.5 | HTR2B, SLC6A4, EDNRB, EDNRA, EDN1, CAV1 | | 4 | negative regulation of endothelial cell proliferation | GO:001937 | 10.5 | XDH, APOE, ACVRL1, GDF2, ENG, CAV2 | | 5 | blood vessel remodeling | GO:001974 | 10.4 | BAX, NOS3, ACVRL1, ELN, BMPR2, CBS | | 6 | negative regulation of fibrinolysis | GO:051918 | 10.4 | SERPINE1, F2, PLG, THBD, THBS1 | | 7 | negative regulation of platelet activation | GO:010544 | 10.3 | THBD, F2, APOE, NOS3, SERPINE2 | | 8 | superoxide metabolic process | GO:006801 | 10.2 | CYBB, NOS2, SOD2, NOX1, SOD1, CBS | | 9 | negative regulation of blood coagulation | GO:030195 | 10.2 | SERPINE2, SERPINE1, APOE, THBD, EDN1 | | 10 | positive regulation of pathway-restricted SMAD protein phosphorylation | GO:010862 | 10.1 | BMPR2, SMAD4, ACVRL1, TGFB1, GDF2, ENG | | 11 | extracellular matrix disassembly | GO:022617 | 10.1 | MMP9, ELANE, MMP3, MMP2, PLG, ENG | | 12 | in utero embryonic development | GO:001701 | 10.0 | EDN1, NOS3, SMAD2, EDNRA, ACVRL1, BMPR1A | | 13 | negative regulation of blood vessel endothelial cell migration | GO:043537 | 9.9 | TGFB1, THBS1, APOE, ACVRL1, GDF2 | | 14 | positive regulation of nitric-oxide synthase activity | GO:051000 | 9.8 | HIF1A, ESR1, AKT1, APOE, HTR2B | | 15 | cellular response to interleukin-1 | GO:071347 | 9.8 | MMP9, RELA, CCL2, PTGIS, HIF1A, NFKB1 | | 16 | regulation of binding | GO:051098 | 9.8 | SMAD3, SMAD2, SMAD4, TGFB1 | | 17 | response to estrogen stimulus | GO:043627 | 9.7 | ESR1, HMOX1, PPARG, TPH2, CAV1, SERPINE1 | | 18 | regulation of transforming growth factor beta receptor signaling pathway | GO:017015 | 9.7 | TGFB1, ENG, SMAD4, SMAD3, SMAD2 | | 19 | positive regulation of smooth muscle cell proliferation | GO:048661 | 9.6 | ELANE, PRKCA, HIF1A, HMOX1, TNF, NOX1 | | 20 | transforming growth factor beta receptor signaling pathway | GO:007179 | 9.6 | SMAD2, ACVRL1, TGFB1, SERPINE1, BMPR1A, ENG | | 21 | positive regulation of endothelial cell proliferation | GO:001938 | 9.6 | GDF2, HTR2B, ACVRL1, CCL2, BMPR2, VEGFA | | 22 | positive regulation of endothelial cell migration | GO:010595 | 9.5 | THBS1, EDN1, ANGPT1, VEGFA, PRKCA, BMPR2 | | 23 | fibrinolysis | GO:042730 | 9.4 | PLAT, SERPINE1, F2, PLAU, PLG | | 24 | regulation of blood pressure | GO:008217 | 9.4 | HMOX1, PPARG, NOS3, EDNRB, NPPB, NPPA | | 25 | lipopolysaccharide-mediated signaling pathway | GO:031663 | 9.3 | TGFB1, LBP, CCL2, TNF, NOS3, TLR2 | | 26 | angiogenesis | GO:001525 | 9.2 | TIE1, HMOX1, CCL2, HIF1A, ACVRL1, PRKCA | | 27 | positive regulation of apoptotic process | GO:043065 | 9.2 | MMP9, BAX, RARG, RARB, ESR2, TNF | | 28 | positive regulation of blood vessel endothelial cell migration | GO:043536 | 9.2 | TGFB1, PRKCA, AKT1, ANGPT1, VEGFA, THBS1 | | 29 | response to mechanical stimulus | GO:009612 | 9.2 | TNF, NOS3, CCL2, MMP9, PRKCA, CAV1 | | 30 | platelet degranulation | GO:002576 | 9.2 | PLG, THBS1, TGFB1, SOD1, VEGFA, SERPINE1 | | 31 | extracellular matrix organization | GO:030198 | 9.1 | ELANE, MMP2, PLG, COL18A1, NFKB2, ELN | | 32 | positive regulation of angiogenesis | GO:045766 | 9.1 | PTGIS, HMOX1, MMP9, VEGFA, SERPINE1, NOS3 | | 33 | negative regulation of cell growth | GO:030308 | 9.0 | PPARG, GDF2, NPPB, NPPA, ESR2, SERPINE2 | | 34 | negative regulation of apoptotic process | GO:043066 | 9.0 | THBS1, ANGPT1, RELA, SERPINE1, VEGFA, SOD2 | | 35 | response to estradiol stimulus | GO:032355 | 9.0 | NOS3, CYP19A1, ESR1, MMP9, RARA, TGFB1 | | 36 | anti-apoptosis | GO:006916 | 8.9 | MPO, SOD1, RELA, ANGPT1, CCL2, AKT1 | | 37 | transcription initiation from RNA polymerase II promoter | GO:006367 | 8.9 | ESR1, RARB, RARA, RARG, SERPINE1, RBPJ | | 38 | positive regulation of MAP kinase activity | GO:043406 | 8.8 | EDN1, VEGFA, HTR2B, TNF, NOX4, PDE5A | | 39 | negative regulation of cell proliferation | GO:008285 | 8.7 | NOS3, SMAD2, SMAD4, PLG, SOD2, PRKCA | | 40 | positive regulation of protein phosphorylation | GO:001934 | 8.5 | ENG, VEGFA, F2, TNF, AKT1, EDNRA | | 41 | platelet activation | GO:030168 | 8.4 | PRKCB, VWF, SERPINE1, PRKCA, VEGFA, F2 | | 42 | gene expression | GO:010467 | 8.4 | PRKCA, PPARA, SMAD4, SMAD3, SMAD2, NR1I2 | | 43 | response to drug | GO:042493 | 8.3 | SLC6A4, NPPB, SOD1, TGFB1, MMP9, CCL2 | | 44 | signal transduction | GO:007165 | 8.2 | NOX1, PLAU, PPARG, TNC, ESR2, ESR1 | | 45 | negative regulation of transcription from RNA polymerase II promoter | GO:000122 | 8.2 | RBPJ, CELA1, SMAD3, ENG, CAV1, ESR2 | | 46 | positive regulation of transcription, DNA-dependent | GO:045893 | 8.0 | PPARA, SMAD2, SMAD3, SMAD4, NFKB1, ACVRL1 | | 47 | inflammatory response | GO:006954 | 7.8 | NPPB, CELA1, TGFB1, TLR2, C4A, NFKB1 | | 48 | blood coagulation | GO:007596 | 7.3 | SOD1, PRKCA, PRKCB, PLG, PRKCG, TGFB1 | | 49 | positive regulation of transcription from RNA polymerase II promoter | GO:045944 | 6.5 | PPARA, PPARG, TNF, RELA, RBPJ, SERPINE1 | | 50 | response to hypoxia | GO:001666 | 6.1 | ECE1, SLC6A4, NPPB, TGFB1, THBS1, HIF1A |
Molecular functions related to hepatopulmonary syndrome according to GeneDecks: (show all 24)
| id | Name | GO ID | Score | Top Affiliating Genes | | 1 | NAD(P)H oxidase activity | GO:016174 | 10.6 | NOX4, DUOX2, DUOX1 | | 2 | lipoteichoic acid binding | GO:070891 | 10.6 | LBP, CD14, TLR2 | | 3 | transforming growth factor beta-activated receptor activity | GO:005024 | 10.6 | ACVRL1, ENG, BMPR2, BMPR1A | | 4 | retinoic acid receptor activity | GO:003708 | 10.5 | RARB, RARA, RARG | | 5 | retinoid X receptor binding | GO:046965 | 10.5 | NR1H4, NR0B2, PPARG, RARG | | 6 | nitric-oxide synthase binding | GO:050998 | 10.2 | SLC6A4, CAV1, CAV3 | | 7 | modified amino acid binding | GO:072341 | 10.2 | NOX4, CBS, MTHFR | | 8 | ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity | GO:004879 | 10.0 | ESR2, PPARG, PPARA, NR1H4, NR1I2 | | 9 | heme binding | GO:020037 | 9.9 | CYP19A1, NOS2, NOS3, NOX4, CYBB, PTGIS | | 10 | flavin adenine dinucleotide binding | GO:050660 | 9.9 | XDH, CYBB, NOS2, NOS3, NOX4 | | 11 | drug binding | GO:008144 | 9.8 | ACE, NR1I2, PPARA, PPARG, ALB, HTR2B | | 12 | serine-type endopeptidase activity | GO:004252 | 9.8 | ELANE, PLG, PLAU, PLAT, F2, F9 | | 13 | iron ion binding | GO:005506 | 9.8 | NOS3, NOS2, CYP19A1, PTGIS, TPH2, TPH1 | | 14 | Gram-positive bacterial cell surface binding | GO:051637 | 9.7 | TLR2, CRP, LBP | | 15 | steroid hormone receptor activity | GO:003707 | 9.5 | PPARA, NR0B2, NR1H4, NR1I2, PPARG, ESR2 | | 16 | heparin binding | GO:008201 | 9.3 | THBS1, ELANE, CCL2, APOE, MPO, VEGFA | | 17 | receptor binding | GO:005102 | 9.3 | CAV1, TNC, NOS2, NPPA, NPPB, GBA | | 18 | transcription regulatory region DNA binding | GO:044212 | 9.0 | HIF1A, NFKB1, SMAD4, SMAD3, PPARG, TNF | | 19 | enzyme binding | GO:019899 | 8.7 | PRKCA, TGFB1, HIF1A, PPARG, HMOX1, ESR2 | | 20 | protein heterodimerization activity | GO:046982 | 8.6 | RUNX1, TGFB1, TLR2, HIF1A, CYBB, APOE | | 21 | identical protein binding | GO:042802 | 8.5 | THBS1, SMAD4, TNF, ESR1, AKT1, APOE | | 22 | sequence-specific DNA binding transcription factor activity | GO:003700 | 8.4 | NR1H4, SMAD2, SMAD3, SMAD4, NFKB1, NFKB2 | | 23 | protein homodimerization activity | GO:042803 | 6.9 | SMAD4, CRP, NOS2, NFKB1, SHBG, TGFB1 | | 24 | protein binding | GO:005515 | 1.7 | GDF2, NFKB1, COL18A1, NOX1, NOS3, NOS2 |
|